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INTRODUCTION
The homeobox gene Hesx1 is a member of the paired-like family of
homeobox proteins and functions as a transcriptional repressor
(Thomas et al., 1995; Hermesz et al., 1996; Dasen et al., 2001).
Hesx1 and its orthologues in other vertebrates (Anf genes) are
expressed in the rostral region of the embryo during gastrulation and
neurulation in all species analysed (Hermesz et al., 1996; Thomas
and Beddington, 1996; Kazanskaya et al., 1997; Knoetgen et al.,
1999). In mouse, Hesx1 expression is very dynamic, and Hesx1
transcripts are detected in anterior regions of the visceral endoderm,
definitive endoderm and neural ectoderm during early development.
Later, Hesx1 expression is restricted to the Rathke’s pouch.
Hesx1-deficient embryos show a reduction in anterior forebrain
(AFB) tissue rostral to the zona limitans intrathalamica (ZLI) at 8.5
dpc. The presumptive AFB is initially induced, but this territory is
reduced at a later stage of development in Hesx1–/– mutants.
Chimeric analysis has shown that this forebrain phenotype is a
consequence of the requirement of Hesx1 within the anterior neural
ectoderm, and not due to disturbances in the anterior visceral
endoderm or anterior definitive endoderm (Martinez-Barbera et al.,
2000). Hesx1 mutants also show defects in dorsal forebrain
commissural structures, eye abnormalities and pituitary dysplasia
(Dattani et al., 1998). A comparable phenotype is observed in a
human congenital disorder called septo-optic dysplasia (SOD).
Indeed, mutations in HESX1 are associated with familial cases of
SOD and other forms of hypopituitarism in humans (Dattani et al.,
1998; Dattani, 2004; Sobrier et al., 2006). In Xenopus,
overexpression of the Hesx1 orthologue, Xanf1, results in
enlargement of the neural plate (NP) at the expense of epidermis and
neural crest (NC) (Ermakova et al., 1999). Thus, it is now established
that Hesx1 is essential for normal AFB development in vertebrates.
However, little is known about how Hesx1 performs its function.
Experiments in Xenopus, zebrafish, chick and mammals have
provided compelling evidence indicating that suppression of
posteriorising signals is an essential requisite for the formation of
anterior neural tissue (Kimura et al., 2000; Perea-Gomez et al.,
2001; Kudoh et al., 2002; Wilson and Houart, 2004; Stern, 2005).
Among them, the Wnt/-catenin pathway plays a key role in
anterior-posterior patterning of the NP [(Yamaguchi, 2001; Wilson
and Houart, 2004; Marikawa, 2006) and references therein]. It is
thought that the action of Wnt signalling inhibitors and activators
create a gradient along the neural ectoderm (high caudally and low
rostrally) that is required for normal anterior-posterior
regionalisation of the NP in distinct subdivisions (Leyns et al.,
1997; Glinka et al., 1998; Hsieh et al., 1999; Kiecker and Niehrs,
2001; Nordstrom et al., 2002). Normal AFB development is
particularly sensitive to Wnt/-catenin signalling (Fredieu et al.,
1997; van de Water et al., 2001; Houart et al., 2002). For instance,
the zebrafish masterblind mutants, which carry a mutation in
Axin1 that abolishes binding to Gsk3 causing Wnt/-catenin
signalling overactivation, show a phenotype in which
telencephalon and eyes are reduced or absent, and dorsal
diencephalic fates are expanded rostrally (van de Water et al.,
2001; Heisenberg et al., 2001). Similarly, lack of Tcf3/Headless
repressor function leads to the loss of anterior neural tissue (Kim
et al., 2000). In chick, it has been shown that posterior forebrain
character can be induced in explants, which would normally
acquire an AFB fate, through the direct caudalising activity of Wnt
proteins (Nordstrom et al., 2002). In mouse, both overexpression
of Wnt8 and lack of Wnt/-catenin antagonists lead to suppression
of anterior neural fates (Popperl et al., 1997; Mukhopadhyay et al.,
2001; Satoh et al., 2004). Therefore, it is now established that
Wnt/-catenin signalling must be modulated during vertebrate
development to allow normal anterior-posterior patterning of the
NP; in particular, Wnt/-catenin signalling needs to be suppressed
for the AFB to develop.
The transcriptional repressors Hesx1, Six3 and Rax (Rx) show
overlapping expression patterns in the anterior neural ectoderm
during early mouse development (Oliver et al., 1995; Thomas and
Beddington, 1996; Mathers et al., 1997). Moreover, Six3 and Rax
mutants show defects in the forebrain, such as reduced
telencephalon and eyes, which are very similar to those observed
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in Hesx1–/– mutants (Mathers et al., 1997; Martinez-Barbera et al.,
2000; Lagutin et al., 2003). A mechanism has been postulated
in which Six3 is thought to directly repress the Wnt1 promoter
and thereby reduce Wnt/-catenin signalling in the AFB.
Whether or not Hesx1 and Rax perform a similar function during
forebrain formation is an important question that remains
unanswered.
To further understand the function of Hesx1 in forebrain
development, we have analysed in detail the neural patterning of
Hesx1 mutant embryos and performed a genetic fate map of Hesx1-
expressing cells in normal embryos and Hesx1 homozygous
mutants. Our data indicate that in the absence of Hesx1 there is a
posterior transformation of the AFB. Contrary to the observations in
the Six3 mutants, HESX1 appears not to directly repress the Wnt1
locus, although absence of Hesx1 leads to an anteriorisation of Wnt1
expression and ectopic activation of the Wnt/-catenin targets Sp5
and Axin2 in the AFB. Gain-of-function experiments suggest that
Hesx1 alone cannot anteriorise posterior neural tissue, but can rescue
the forebrain defects of the Hesx1-deficient mutants.
MATERIALS AND METHODS
Generation of the Hesx1Cre/+ mouse line
The Hesx1-Cre targeting vector was generated by replacing the Hesx1 coding
region with Cre recombinase (Fig. 4). CCE embryonic stem cells (129/SvEv)
(kindly provided by E. Robertson, Wellcome Trust Centre for Human
Genetics, Oxford, UK) were electroporated and 500 colonies were picked,
expanded and screened as described (Dattani et al., 1998). Two correctly
targeted clones were isolated and injected into blastocysts from C57BL/6J
mice. The PGK-Neo cassette was excised by crossing heterozygous mice
with the ACTB:FLPe strain (Rodriguez et al., 2000). Hesx1Cre/+ mice were
maintained on the C57BL/6J background and to date have been backcrossed
a total of eight times. Hesx1Cre/Cre embryos showed the forebrain and pituitary
defects observed in Hesx1–/– mutants. It is worth noting that the severity of
the phenotype of the Hesx1-deficient embryos (Hesx1Cre/Cre and Hesx1–/–) has
increased compared with the initial analysis (Dattani et al., 1998). No viable
homozygous mice are now identified at weaning and eye defects are fully
penetrant with variable expressivity. We think this is a consequence of
maintaining the colony on the C57BL/6J, whereas it was previously kept on
a C57BL/6 inbred colony maintained at the National Institute for Medical
Research, UK.
Generation of the R26Cond-Hesx1/+ mouse line
The components of the Rosa26 (R26) targeting vectors were a gift (Soriano,
1999; Srinivas et al., 2001). To avoid possible interference with the translation
of Hesx1 owing to the presence of an ATG within the loxP sites, we generated
a pBigT-invloxP by inverting the orientation of both loxP sites (Ivanova et al.,
2005). After electroporation, a total of 300 clones were picked, expanded and
frozen (see Fig. S6 in the supplementary material). Five correctly targeted
clones were identified and two were used for blastocyst injection (C57BL/6J
background). R26Cond-Hesx1/+ heterozygous mice were backcrossed three
times with C57BL/6J mice and then intercrossed to generate
R26Cond-Hesx1/Cond-Hesx1 homozygous mice, all of which were viable and
fertile.
Genetic crosses
Hesx1Cre/+mice were crossed with R26Cond-lacZ/Cond-lacZ reporter animals to
generate the Hesx1Cre/+;R26Cond-lacZ/+ compound mice, then backcrossed to
R26Cond-lacZ/Cond-lacZ mice to obtain Hesx1Cre/+;R26Cond-lacZ/Cond-lacZ mice and
embryos. Hesx1Cre/+;R26Cond-lacZ/+ and Hesx1Cre/–;R26Cond-lacZ/+ embryos
were generated from crosses between Hesx1Cre/+;R26Cond-lacZ/Cond-lacZ and
Hesx1+/– mice. Hesx1+/– mice carry a null allele and have been described
previously (Dattani et al., 1998).
Genotyping of mice and embryos
Embryos and neonates were genotyped by PCR on DNA samples prepared
from tail tips, yolk sacs or whole embryos. Primer sequences and PCR
protocols are available on request.
Histology, X-Gal staining, in situ hybridisation (ISH), TUNEL
staining and cell proliferation
Histology, X-Gal staining, TUNEL staining and ISH were performed as
described (Martinez-Barbera et al., 2002). Proliferation was assessed using
the anti-phospho-histone H3 antibody (mitosis marker; Upstate
Biotechnology). Three embryos of each genotype at similar developmental
stages were embedded in wax and sectioned. Immunostaining was
performed following standard procedures and sections were counterstained
with DAPI. For analysis, a total of over 5,000 nuclei were counted from
matching sections containing forebrain tissue. The mitotic index was
expressed as a percentage of mitotic nuclei from the total number of nuclei.
EMSA, cell transfections, luciferase assays and western blots
EMSA was performed as previously described (Dattani et al., 1998). DNA
transfections were carried out in CHO and 293 cells as described (Brickman
et al., 2001) using reporter plasmids encompassing specific regions of the
Wnt1 locus containing putative Hesx1-binding sites. The western blot for
HESX1 used a specific rabbit serum we have generated.
qRT-PCR and RT-PCR analysis
Total RNA was isolated from embryos using the RNeasy Micro Kit
(Qiagen). First-strand cDNA synthesis was performed using the Omniscript
RT Kit (Qiagen) according to the manufacturer’s recommendations.
Amplification of Hesx1, Cre and Gapdh (endogenous control) with specific
primers was performed using SYBRGreenER (Invitrogen) on an ABI 7500
Real-Time PCR machine (Applied Biosystems) and analysed using the ABI
system software. For RT-PCR analysis, specific primers for Hesx1, Cre and
Gapdh were used to amplify cDNA templates from RNA extracted from
whole embryos or specific regions of the neural tube using Trizol
(Invitrogen). Primer sequences and PCR conditions are available on request.
RESULTS
Posterior transformation of AFB in Hesx1-
deficient embryos
We have previously shown that in the absence of Hesx1 there is a
lack of AFB tissue at 8.5 dpc, but the reasons underlying this
phenotype are not known (Martinez-Barbera et al., 2000). To find
out the cellular basis of the early forebrain defects, we analysed
neural patterning, proliferation and apoptosis of Hesx1–/– in
comparison with Hesx1+/– and wild-type embryos from 7.5 to 9.5
dpc.
At presomitic stages, the expression domains of Six3 (AFB
marker), Atx (Dmbx1) and Pax2 (posterior forebrain and midbrain
markers at these stages), and Hoxb1 (hindbrain marker) were
identical in all genotypes (Fig. 1A,B and data not shown) (Oliver et
al., 1995; Nornes et al., 1990; Hunt and Krumlauf, 1991; Gogoi et
al., 2002). At the 0- to 1-somite stage, Pax6 is expressed in the
prospective forebrain region of the developing mouse embryo
(Walther and Gruss, 1991). Pax6 expression in the anterior NP was
significantly reduced in Hesx1–/– mutants when compared with
Hesx1+/– or wild-type littermates at this stage, thus confirming that
the prospective forebrain region is reduced only at the early somite
stage (Fig. 1C) (Martinez-Barbera et al., 2000). The possibility that
prospective forebrain was being respecified was analysed using the
neural crest (NC) markers Pax3 and Foxd3. These markers are
expressed on the margin of the anterior NP at the 2- to 3-somite stage
in wild-type embryos, but the most rostral region is free of Pax3 and
Foxd3 transcripts (Fig. 1D,F,H,J) (Goulding et al., 1991; Labosky
and Kaestner, 1998). By contrast, their expression domains were
anteriorised in the 2- to 3-somite stage Hesx1–/– mutants, and the
region devoid of Pax3 and Foxd3 expression was clearly reduced
when compared with Hesx1+/– or wild-type embryos (Fig.
1E,G,I,K). It is important to note that these changes were observed
prior to a gross lack of neural tissue, although there was a slight
change in the shape of the anterior NP (Figs 1 and 2; see below). NC
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cells are posterior NP derivatives that delaminate from the
boundaries of the NP along the entire axis, with the exception of the
most anterior neural ectoderm fated to be AFB (Couly and Le
Douarin, 1987; Sechrist et al., 1995; Muhr et al., 1997). Therefore,
our data suggest that the AFB loses its identity in Hesx1–/– mutants
in favour of NC.
Wnt/-catenin ectopic activation in the AFB of
Hesx1–/– mutants
We analysed the expression patterns of Wnt1 and Fgf8 because they
are essential signals required for normal expansion and patterning
of midbrain and AFB, respectively (McMahon and Bradley, 1990;
Echelard et al., 1994; Meyers et al., 1998; Storm et al., 2006). In the
3- to 4-somite wild-type embryo, there was a segment of the NP that
expressed Wnt1 (prospective midbrain), but the most anterior part of
the NP was devoid of Wnt1 transcripts (Fig. 2A). By contrast, in
Hesx1–/– mutants, the Wnt1 expression domain was expanded
rostrally throughout the edge of the NP until its most anterior tip
(Fig. 2B). This anteriorisation was not observed at earlier stages, but
Wnt1 expression is barely detectable at the 2-somite stage (Echelard
et al., 1994). The onset of Fgf8 expression in the anterior neural
ridge (ANR) occurs at the 4- to 5-somite stage in wild-type embryos
(Crossley and Martin, 1995; Shimamura and Rubenstein, 1997). At
this stage, the Fgf8 expression domain in the ANR was either
reduced or absent in Hesx1-null mutants (Fig. 2C-F).
To check whether Wnt/-catenin signalling was ectopically
activated within the prospective AFB, we analysed the expression of
the Wnt/-catenin targets Axin2 and Sp5 (Jho et al., 2002; Takahashi
et al., 2005; Weidinger et al., 2005). Normally, Axin2 and Sp5 are
not expressed in the most anterior region of the NP of the 2- to 3-
somite stage wild-type embryo (Fig. 2K,M and data not shown).
Strikingly, Axin2 expression was anteriorised in the mutants as
compared with wild-type littermates at the 3- to 4-somite stage (Fig.
2G,H). Likewise, Sp5 transcripts were detected all over the anterior
NP of Hesx1–/– mutants at the 2- to 3-somite and 5- to 6-somite
stages (Fig. 2I-N). Taken together, this marker analysis suggests that
the lack of Hesx1 leads to the ectopic activation of Wnt/-catenin
signalling in the prospective AFB prior to the onset of Fgf8
expression in the ANR.
Rostral expansion of dorsal diencephalic markers
in Hesx1–/– mutants
The anterior expansion of posterior neural markers was also evident
in Hesx1 mutant embryos at the 8-to 10-somite stage, although at
these stages there was a marked reduction of AFB tissue. Pax3 and
Foxd3 expression domains did not reach the most anterior region of
the developing forebrain in the wild type and heterozygous Hesx1
mutants, but did so in Hesx1–/– mutants (Fig. 3A-D) (Goulding et al.,
1991; Labosky and Kaestner, 1998). Wnt1 is normally expressed in
the midbrain and posterior diencephalon, whereas Wnt3a is
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Fig. 1. Posterior transformation of
the AFB in Hesx1–/– mutants at
early somite stages. (A,B) Dorsal
view of the Pax2 expression domain in
wild type (A) and Hesx1–/– mutant (B)
at presomitic stages. No significant
differences are observable. (C) Dorsal
view of the Pax6 expression domain in
wild type (left) and Hesx1–/– mutant
(right) at the 0- to 1-somite stage.
Note the reduction in Pax6 expression
in the anterior NP (arrowheads).
(D-G) Dorsal (D,E) and frontal (F,G) views of Pax3 expression domain in wild type (D,F) and Hesx1–/– mutant (E,G) at the 2- to 3-somite stage. Pax3
expression domain is anteriorised in the Hesx1–/– mutant (E,G). Arrowheads indicate the rostral limit of Pax3 expression. (H-K) Dorsal (H,I) and
frontal (J,K) views of Foxd3 expression domain in wild type (H,J) and Hesx1–/– mutant (I,K) at the 2- to 3-somite stage. Foxd3 expression domain is
anteriorised in the Hesx1–/– mutant (I,K). Arrowheads indicate the rostral limit of Foxd3 expression. Anterior is to the top in A-E,H,I.
Fig. 2. Wnt/-catenin pathway is activated in the AFB of Hesx1–/–
mutants at early somite stages. (A,B) Rostral view of the Wnt1
expression domain in wild type (A) and Hesx1–/– mutant (B) at the 3- to
4-somite stage. Wnt1 transcripts do not reach the rostral tip of the NP
in wild-type embryos, but do so in Hesx1–/– mutants (arrowhead).
(C-F) Frontal (C,D) and lateral (E,F) views of the Fgf8 expression domain
in wild type (C,E) and Hesx1–/– mutant (D,F) at the 4- to 5-somite stage.
Fgf8 expression in the anterior neural ridge (ANR) is reduced in the
Hesx1–/– mutant. Arrowheads in C,D indicate the posterior limit of the
Fgf8 expression domain in the ANR. (G,H) Expression of the Wnt/-
catenin target Axin2 in wild type (G) and Hesx1–/– mutant (H) at the 3-
to 4-somite stage. Dorsal view, anterior is to the bottom. Note the
expansion of the Axin2 expression domain in the Hesx1–/– mutant (H).
Arrowheads indicate the rostral limit of Axin2 expression. (I-N) Dorsal
(I-L) and lateral (M,N) views of the expression domain of the Wnt/-
catenin target Sp5 in wild type (I,K,M) and Hesx1–/– mutant (J,L,N) at
the 5- to 6-somite (I,J) and the 2- to 3-somite (K-N) stages. Anterior is
to the bottom (I-L) or to the left (M,N). Note the expansion of Sp5
expression throughout the anterior NP in the Hesx1 mutant (J,L,N). Only
the most rostromedial region of the NP is free of Sp5 transcripts
(arrowheads indicate the rostral limit of Sp5 expression).
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expressed only in the dorsal diencephalon (Parr et al., 1993). At
these stages, Wnt1 and Wnt3a were also clearly anteriorised and
their expression domains were enlarged (Fig. 3I-P). Therefore, the
Wnt1 and Wnt3a anteriorisation might reflect the transformation of
AFB into posterior diencephalic fates observed at earlier stages. The
expression domains of Pax2, Fgf8, Pax6 and Six3 in the AFB region
were significantly reduced in Hesx1–/– mutants at 8.5 dpc (Fig. 3G,H
and data not shown) (Nornes et al., 1990; Crossley and Martin, 1995;
Walther and Gruss, 1991; Oliver et al., 1995). However, more-
posterior markers, such as En1 (a midbrain-hindbrain boundary
marker) and Hoxb1 (hindbrain marker) were unperturbed in Hesx1-
deficient embryos (Fig. 3E,F and data not shown) (Wurst et al.,
1994; Hunt and Krumlauf, 1991). At 9.5 dpc, rostral expansion of
the Atx and Pax6 expression domains in the posterior diencephalic
region was evident in Hesx1–/– mutants (see Fig. S1A,B in the
supplementary material).
A reduction in cell proliferation in the anterior NP and/or an
increase in cell death might also contribute to the forebrain defects
observed in Hesx1-deficient embryos. Proliferation and apoptosis in
the NP were analysed using an anti-phosphorylated histone H3
antibody and TUNEL staining, respectively. No significant
differences were observed in the mitotic indices between Hesx1–/–
(4.29%) and wild-type (4.72%) embryos from 7.5 to 8.5 dpc.
Likewise, cell death was negligible within the anterior NP at streak
and head-fold stages and no significant differences were observed
between Hesx1–/– and wild-type littermates at 8.5 dpc (see Fig. S1I-
L in the supplementary material). However, at 9.5 dpc, Hesx1–/–
mutants exhibited exacerbated apoptosis within neural tissue at the
level of the posterior forebrain-midbrain boundary. Cell death in the
roof plate of the telencephalon was reduced as compared with that
in heterozygous or wild-type littermates (see Fig. S1C-F in the
supplementary material). Since enhanced apoptosis occurs in a
domain of the forebrain where Hesx1 is never expressed and after
the onset of forebrain defects, we conclude it is an indirect effect of
the abnormal development of the forebrain in Hesx1 mutants.
Altogether, these data indicate that the reduction of AFB tissue in
Hesx1 mutants from 8.5 dpc onwards is caused by the
posteriorisation of AFB precursors at early somite stages.
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Fig. 3. Rostral expansion of dorsal diencephalic markers in
Hesx1–/– mutants at the 8- to 10-somite stage. (A-D) Frontal views
of the Pax3 (A,B) and Foxd3 (C,D) expression domains in wild type (A,C)
and Hesx1–/– mutants (B,D). Both expression domains are anteriorised in
the Hesx1–/– mutants. Arrowheads indicate the rostral limit of Pax3 and
Foxd3 expression. (E,F) Lateral view of the En1 expression domain in
wild type (E) and Hesx1–/– mutant (F). En1 expression domain around
the midbrain-hindbrain region is normal in Hesx1–/– mutants when
compared with wild-type littermates. (G,H) Lateral view of the Pax2
expression domain in wild type (G) and Hesx1–/– mutant (H). Pax2
expression around the midbrain-hindbrain boundary is normal
(arrowheads), but there is no Pax2 expression in the AFB of the Hesx1–/–
mutant (arrow in G). (I,J) Lateral view of the Wnt1 expression domain in
wild type (I) and Hesx1–/– mutant (J). In the mutant, Wnt1 expression is
expanded rostrally until the tip of the NP (arrowhead). (K,L) Dorsal view
of the embryos depicted in I,J with anterior to the bottom.
(M,N) Lateral view of the Wnt3a expression domain in wild type (M)
and Hesx1–/– mutant (N). Note the rostral expansion of Wnt3a
expression in the prospective dorsal diencephalon (bracket).
(O,P) Dorsal view of the embryos depicted in M and N with anterior to
the bottom.
Fig. 4. Generation of the Hesx1-Cre targeted allele. (A) Top to
bottom: structure of the murine Hesx1 wild-type locus, Hesx1-Cre
targeting vector and Hesx1-Cre allele prior to and after flipase excision
of the neo cassette. The map of the targeting vector shows the
replacement of the Hesx1 coding region by a cassette containing the
Cre recombinase gene and the neomycin resistance gene under the
PGK promoter (PGK-Neo) flanked by Frt sites (red triangles).
(B) Southern blot hybridisation of DNA samples from wild type (+/+)
and two heterozygous (Cre/+) ES cell clones cut with EcoRI and
hybridised with an external probe (brown line in A). (C) Representative
example of PCR genotyping of DNA samples from wild-type, Hesx1Cre/+
and Hesx1Cre/Cre embryos. (D) Wild-type embryo (left) and Hesx1Cre/Cre
mutant showing lack of AFB tissue (telencephalon and eye).
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Cell fate analysis of Hesx1-expressing cells in
normal and Hesx1-deficient embryos
We carried out genetic fate mapping of Hesx1-expressing cells using
a novel Hesx1-Cre mouse line (Fig. 4) and the R26-floxstop-lacZ
reporter line (hereby called R26-Cond-lacZ) (Soriano, 1999). X-Gal
staining of Hesx1Cre/+;R26Cond-lacZ/Cond-lacZ embryos, which are
phenotypically normal, revealed lacZ expression in all cell types
where Hesx1 is normally expressed and their descendants (see Fig. S2
in the supplementary material). This analysis revealed that the normal
fate of Hesx1-expressing cells within the NP is to colonise the AFB.
This fate analysis was also performed on Hesx1-deficient
embryos. By comparing Hesx1Cre/+;R26Cond-lacZ/+ and
Hesx1Cre/–;R26Cond-lacZ/+ compound embryos, differences in the fate
of lacZ-expressing cells between genotypes could be attributed to
the loss of Hesx1, as Cre and lacZ dosage is the same in both.
First, we analysed the Cre expression pattern in Hesx1Cre/+,
Hesx1Cre/– and Hesx1Cre/Cre embryos. ISH on Hesx1Cre/Cre embryos
at 8.5 dpc revealed a pattern of Cre expression that was very similar
to the Hesx1 expression domain in wild-type embryos (see Fig. S3A-
C in the supplementary material). No differences in Cre expression
were observed between Hesx1Cre/+ and Hesx1Cre/– embryos,
although the intensity of the expression domain was weaker in
embryos carrying just one copy of Cre (see Fig. S3D,E in the
supplementary material). RT-PCR on Hesx1Cre/+ and Hesx1Cre/–
embryos from 7.5-9.5 dpc detected Cre expression at all stages
analysed, but no expression was detected in the brain of 11.5-dpc
embryos (data not shown). qRT-PCR revealed no differences in Cre
expression between Hesx1Cre/+ and Hesx1Cre/– embryos at the 2-
somite stage, but a reduction in Cre expression was observed in
Hesx1Cre/– embryos at the 5-somite stage, possibly reflecting the
ongoing posterior transformation of the AFB (see Fig. S3F in the
supplementary material). These data suggest that there is no ectopic
expression of Cre within the NP of Hesx1-deficient embryos.
No significant differences in X-Gal staining were observed from
the onset of gastrulation to the 2- to 3-somite stage between
Hesx1Cre/+;R26Cond-lacZ/+ and Hesx1Cre/–;R26Cond-lacZ/+ embryos (see
Fig. S2B and Fig. S4F in the supplementary material). However, at
the 4- to 5-somite stage, X-Gal-positive cells reached more posterior
regions of the NP in Hesx1Cre/–;R26Cond-lacZ/+ embryos as compared
with Hesx1Cre/+;R26Cond-lacZ/+ littermates (Fig. 5A,B). The majority
of lacZ-expressing cells in Hesx1Cre/+;R26Cond-lacZ/+ compound
embryos at the 8- to 10-somite stage remained anterior to the point
of fusion between the cranial folds at the boundary between anterior
and posterior forebrain (Fig. 5C). By contrast, abundant lacZ-
expressing cells were observed posterior to this boundary in
Hesx1Cre/–;R26Cond-lacZ/+ mutants (Fig. 5D). These differences were
accentuated at 9.5 dpc. Moreover, lacZ-expressing cells also
colonised the first branchial arch in Hesx1Cre/–;R26Cond-lacZ/+
embryos from 9.5 dpc in a manner resembling the pattern of
endogenous NC migration (Fig. 5I-N). This was never observed in
Hesx1Cre/+;R26Cond-lacZ/+ embryos (n=52). The possibility that lacZ-
expressing cells in the first branchial arch were migratory NC was
in agreement with the rostral expansion of the NC markers Pax3 and
Foxd3 (Fig. 1D-K and Fig. 3A-D). In fact, at 16.5 dpc, lacZ-
expressing cells were found in skull bones, dermis, maxilar
and mandibular bones, basisphenoid and vibrissae of
Hesx1Cre/–;R26Cond-lacZ/+ mutants, which are all tissues normally
colonised by cranial NC (see Fig. S4 in the supplementary material,
and data not shown) [Creuzet et al. (Creuzet et al., 2005) and
references therein]. No differences in X-Gal staining were observed
in the endoderm of the pharyngeal arches and the liver between the
two genotypes.
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Fig. 5. Descendants of Hesx1-expressing cells in the anterior NP
colonise posterior regions of the neural tube and the first
branchial arch. All embryos were X-Gal stained. (A,B) Higher
numbers of lacZ-expressing cells reach more posterior regions of the
NP in the Hesx1Cre/–;R26Cond-lacZ/+ mutant (B, arrowhead) as compared
with a Hesx1Cre/+;R26Cond-lacZ/+ embryo (A) at the 6- to 7-somite stage.
(C,D) This is accentuated in an 8- to 10-somite Hesx1Cre/–;R26Cond-lacZ/+
mutant (D) as compared with an Hesx1Cre/+;R26Cond-lacZ/+ embryo (C).
Arrowhead in C indicates the boundary between anterior and
posterior forebrain. (E-H) Lateral (E,F) and dorsal (G,H) views of a
Hesx1Cre/+;R26Cond-lacZ/+ embryo (E,G) and a Hesx1Cre/–;R26Cond-lacZ/+
mutant (F,H). The brain was partially dissected to improve X-Gal
staining. lacZ-expressing cells barely colonise the posterior forebrain
of the Hesx1Cre/+;R26Cond-lacZ/+ embryo (arrowheads in E,G), but
massively populate this region in the Hesx1Cre/–;R26Cond-lacZ/+ mutant
(black arrowheads in F,H). Note that the Hesx1Cre/–;R26Cond-lacZ/+
mutant depicted in F,H shows asymmetric telencephalic development
with a very small right telencephalic vesicle. This is concomitant with
a more pronounced degree of colonisation of lacZ-expressing cells on
the right side of the posterior forebrain (white arrowhead).
(I,J) Hesx1Cre/+;R26Cond-lacZ/+ embryo (I) and Hesx1Cre/–;R26Cond-lacZ/+
mutant (J) at 9.5 dpc. Note the presence of lacZ-expressing cells
within the first branchial arch in the Hesx1Cre/–;R26Cond-lacZ/+ mutant
only (J). (K-N) Frontal sections of a Hesx1Cre/+;R26Cond-lacZ/+ embryo
(K,M) and a Hesx1Cre/–;R26Cond-lacZ/+ mutant (L,N) at 10.5 dpc. Many
more lacZ-expressing cells are localised in the frontonasal mass
(arrowheads in L) of the Hesx1Cre/–;R26Cond-lacZ/+ mutant embryos as
compared with the Hesx1Cre/+;R26Cond-lacZ/+ embryo (K). lacZ-
expressing cells within the first branchial arch are only observed in the
Hesx1Cre/–;R26Cond-lacZ/+ embryo. ba-I, first branchial arch; dd, dorsal
diencephalon; dt, dorsal telencephalon; op, olfactory placode; rp,
Rathke’s pouch; vt, ventral telencephalon.
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At 12.5 dpc, most of the lacZ-expressing cells colonised the
telencephalic vesicles, eyes, hypothalamus and ventral diencephalon
in the Hesx1Cre/+;R26Cond-lacZ/+ embryos, and only sporadic stained
cells were observed within the frontonasal mass and the posterior
forebrain (Fig. 5E,G). By contrast, Hesx1Cre/–;R26Cond-lacZ/+ embryos
showed an abundance of lacZ-expressing cells in the posterior
forebrain and frontonasal mass, in addition to the ectopic lacZ-
expressing cells within the first branchial arch (Fig. 5F,H and data
not shown). We noticed that Hesx1-deficient embryos at 11.5-12.5
dpc had more lacZ-expressing cells localised in the AFB (Fig. 5E,F).
Since Cre expression is not activated ectopically within the NP, this
finding might be due to the fact that in these embryos the AFB
derives predominantly from the most rostro-medial (RM) region of
the early NP, as more lateral regions change fate to posterior
forebrain and NC (Figs 1 and 2). The RM region of the NP contains
a higher density of lacZ-expressing cells than more lateral regions
(see Fig. S2B and Fig. S4F in the supplementary material). By
contrast, the AFB of Hesx1Cre/+;R26Cond-lacZ embryos derives from
regions of the early anterior NP, containing both high and low
densities of lacZ-expressing cells.
Often, asymmetric development of the telencephalic and optic
vesicles was observed in Hesx1Cre/–;R26Cond-lacZ/+ mutants (~75%,
n=134), in agreement with previous observations (Dattani et al.,
1998). In these embryos, one side developed better than the other,
with the right side commonly being the most severely affected
(95%) (Fig. 5H). The greater reduction of telencephalic and eye
tissue was concomitant with an increased colonisation of X-Gal-
positive cells in the posterior forebrain of the same side. This
suggests that more cells that would normally colonise the
telencephalon and eyes have reverted their fate to posterior
forebrain in the most-affected side. The reasons underlying the
asymmetry defects in Hesx1-deficient embryos remain unknown at
present, as Hesx1 is not expressed asymmetrically within the NP.
X-Gal staining on whole brains followed by ISH with Shh and Pax6
revealed that lacZ-expressing cells did not cross the forebrain-
midbrain boundary, which is marked by the posterior limit of Pax6
expression in the forebrain (Inoue et al., 2000) (see Fig. S5 in the
supplementary material).
Taken together, these data indicate that a lack of Hesx1 expression
causes a transformation of the AFB primordium, which acquires a
posterior forebrain identity and generates NC.
Hesx1 might not be sufficient to change posterior
neural fates
If a lack of Hesx1 leads to a posteriorisation of the forebrain, could
Hesx1 misexpression alter posterior fates when ectopically
expressed? To address this issue we generated a R26-Cond-Hesx1
mouse line by gene targeting in ES cells (see Fig. S6 in the
supplementary material). In this mouse, Hesx1 expression is
activated upon Cre-mediated excision of the stop cassette.
R26Cond-Hesx1/+ mice were crossed with the -Actin-Cre transgenic
line, in which Cre expression is driven by the -Actin (Actb)
promoter (Meyers et al., 1998). R26Cond-Hesx1/+;-Actin-Cre
compound embryos expressed Hesx1 transcripts ubiquitously
(except in the heart where -Actin is not active), whereas
R26Cond-Hesx1/+, -Actin-Cre and wild-type littermates expressed
Hesx1 only within the endogenous domain in the ventral forebrain
and/or Rathke’s pouch (see Fig. S6D,E in the supplementary
material). Western blot analysis of whole heads demonstrated that
R26Cond-Hesx1/+;-Actin-Cre compound embryos contained more
HESX1 protein than R26Cond-Hesx1/+, -Actin-Cre or wild-type
littermates (see Fig. S6F in the supplementary material). Protein
levels were even higher when embryos contained two copies of the
R26-Cond-Hesx1 allele in R26Cond-Hesx1/Cond-Hesx1;-Actin-Cre
compound embryos (data not shown).
Marker analysis revealed no significant differences in the
expression of Six3, Pax3, Foxd3, Wnt1 and Fgf8 between
R26Cond-Hesx1/+;-Actin-Cre, R26Cond-Hesx1/Cond-Hesx1;-Actin-Cre,
single mutants and wild-type littermates (data not shown).
Therefore, it seems likely that Hesx1 is not sufficient to confer
anterior identity to posterior neural tissues. However, a proportion
of compound embryos overexpressing Hesx1 had exencephaly
(10% of R26Cond-Hesx1/+;-Actin-Cre, n=65; and 80% of
R26Cond-Hesx1/Cond-Hesx1;-Actin-Cre, n=35) (see Fig. S6E in the
supplementary material). The reasons underlying the exencephaly
are at present unknown, but this phenotype is background-dependent
and not detected in a mixed C57BL6/J;CD1 background (data not
shown).
AFB is likely to exhibit a differential sensitivity to
Hesx1 levels
We used the R26-Cond-Hesx1 mouse line in an attempt to rescue the
forebrain defects of the Hesx1 homozygous mutants. Controlling the
Hesx1 dosage from the R26 locus, by adding either one or two
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Fig. 6. Genetic rescue of the forebrain defects in the Hesx1-
deficient embryos. (A,B) 12.5-dpc wild-type (A) and Hesx1Cre/Cre (B)
embryos. Note the small telencephalic vesicle and the absence of the eye
in the mutant embryo (B). (C,D) 12.5-dpc Hesx1Cre/Cre;R26Cond-Hesx1/+
compound embryos. Note the significant rescue of telencephalic
development, but very little (D) or no rescue (C) of the eye defects.
(E,F) 12.5-dpc Hesx1Cre/Cre;R26Cond-Hesx1/ Cond-Hesx1 compound embryos
showing significant rescue of both telencephalon and eye development.
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copies on a Hesx1-null background, might reveal distinct
requirements for HESX1 protein levels for normal development of
specific AFB structures.
R26Cond-Hesx1/Cond-Hesx1 homozygous animals were crossed with
Hesx1Cre/+ mice to generate Hesx1Cre/+;R26Cond-Hesx1/+ compound
heterozygotes. Table 1 summarises the results of all genotypes
determined at weaning in the offspring of Hesx1Cre/+;R26Cond-Hesx1/+
intercrosses. As expected, no Hesx1Cre/Cre animals were obtained
(see Materials and methods). However, five mice of
Hesx1Cre/Cre;R26Cond-Hesx1/+ and four mice of
Hesx1Cre/Cre;R26Cond-Hesx1/Cond-Hesx1 genotype were identified.
All exhibited eye abnormalities, except for one
Hesx1Cre/Cre;R26Cond-Hesx1/Cond-Hesx1 mouse that had normal eyes.
These data suggest that the addition of HESX1 from the R26-Cond-
Hesx1 allele can rescue the perinatal lethality observed in the Hesx1
homozygous mutants.
To assess the degree of rescue of AFB structures,
Hesx1Cre/+;R26Cond-Hesx1/+ mice were intercrossed and 12.5-dpc
embryos were subject to morphological and histological analyses.
Hesx1Cre/Cre embryos obtained from Hesx1Cre/+;R26Cond-Hesx1/+
intercrosses showed reduced or absent telencephalon, but eye defects
were fully penetrant with variable expressivity ranging from
unilateral microphthalmia to bilateral anophthalmia (n=7) (Fig. 6B)
(Dattani et al., 1998). By contrast, Hesx1Cre/Cre;R26Cond-Hesx1/+
embryos showed a significant improvement in AFB development
(Fig. 6C,D). The size and shape of the telencephalic vesicles in
Hesx1Cre/Cre;R26Cond-Hesx1/+ embryos was comparable with wild-type
littermates in nine out of 12 embryos. However, there was no major
improvement in eye development. Of the embryos recovered, all had
abnormal eyes (n=12), and either showed bilateral anophthalmia
(n=10) or unilateral microphthalmia (n=2). Eye phenotype rescue
was accentuated in Hesx1Cre/Cre;R26Cond-Hesx1/Cond-Hesx1 compound
embryos (Fig. 6E,F). Bilateral anophthalmia was observed in only
three out of ten embryos. From the remaining seven embryos, three
had normal eyes, two had bilateral microphthalmia and two
unilateral anophthalmia. Telencephalic development was normal in
nine out of ten embryos analysed. No phenotypic defects were seen
in embryos of all other genotypes. The results from these
experiments allow us to draw two conclusions. First, that Hesx1
expression from the R26-Cond-Hesx1 allele can rescue the forebrain
defects in Hesx1-deficient embryos. Second, that the telencephalon
and eyes might exhibit a distinct sensitivity to HESX1 dosage.
The rescue of the forebrain defects was analysed at the molecular
level in 8.5-dpc embryos. Hesx1 expression was restricted to the
AFB in Hesx1Cre/Cre;R26Cond-Hesx1/Cond-Hesx1 and wild-type
littermates and levels of expression were comparable (Fig. 7A,B).
Foxd3 expression was anteriorised in the Hesx1-deficient embryos
(Fig. 3C,D), but the Foxd3 expression domain in
Hesx1Cre/Cre;R26Cond-Hesx1/Cond-Hesx1 was similar to that of wild-type
embryos (Fig. 7C,D). Finally, the anteriorisation of Axin2
expression in the Hesx1–/– mutants (Fig. 2G,H) was reverted in
Hesx1Cre/Cre;R26Cond-Hesx1/Cond-Hesx1 compound embryos, and an
Axin2-free region of the anterior NP was evident (Fig. 7E,F).
Overall, these experiments suggest that the rescue of the
morphological forebrain defects correlates with an improvement of
the neural patterning of the anterior NP.
DISCUSSION
It has been previously established that Hesx1 is essential for normal
forebrain formation in mouse and humans, but the mechanisms
underlying the forebrain defects of Hesx1-deficient embryos have
remained elusive (Dattani et al., 1998; Martinez-Barbera et al.,
2000). In this study we demonstrate that lack of Hesx1 leads to a fate
transformation of anterior to posterior forebrain. Cells that normally
colonise the telencephalon, eyes, hypothalamus and ventral
diencephalon are found in more-posterior regions, such as the dorsal
thalamus and pretectum in Hesx1–/– mutants. Gain-of-function
experiments indicate that Hesx1 neither promotes AFB identity
when misexpressed in the posterior NP, nor increases the size of the
AFB when overexpressed in its endogenous expression domain.
Moreover, our experiments suggest that the eyes might require
higher levels of HESX1 protein than the telencephalon for normal
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Table 1. Genotype of mice resulting from Hesx1Cre/+;R26Hesx1/+
intercrosses
Number of embryos
Genotype Obtained Expected (%)
Hesx1+/+;R26+/+ 8 7-8 (6.25)
Hesx1+/+;R26Hesx1/+ 23 15 (12.5)
Hesx1+/+;R26Hesx1/Hesx1 9 7-8 (6.25)
Hesx1Cre/+;R26+/+ 14 15 (12.5)
Hesx1Cre/+;R26Hesx1/+ 39 30 (25)
Hesx1Cre/+;R26Hesx1/Hesx1 19 15 (12.5)
Hesx1Cre/Cre;R26+/+ 0 7-8 (6.25)
Hesx1Cre/Cre;R26Hesx1/+ 5 15 (12.5)
Hesx1Cre/Cre;R26Hesx1/Hesx1 4 7-8 (6.25)
Total number of embryos 121
Mice were genotyped at weaning.
Fig. 7. AFB patterning is improved in
Hesx1Cre/Cre;RosaCond-Hesx1/Cond-Hesx1 compound embryos.
(A,B) Frontal view of the Hesx1 expression domain in wild type (A) and
in a Hesx1Cre/Cre;RosaCond-Hesx1/Cond-Hesx1 compound embryo (B), showing
comparable levels of expression. (C,D) Dorsal view of Foxd3 expression
domain in wild type (C) and in a Hesx1Cre/Cre;RosaCond-Hesx1/Cond-Hesx1
compound embryo (D). Arrowheads indicate the region of the rostral
NP where Foxd3 is not expressed. (E,F) Frontal view of Axin2 expression
domain in wild type (E) and in a Hesx1Cre/Cre;RosaCond-Hesx1/Cond-Hesx1
compound embryo (F). Arrowheads indicate the rostral limit of Axin2
expression. Note the presence of AFB tissue that is devoid of Axin2
transcripts in E and F.
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development. This study has revealed that one of the functions of
Hesx1 is to prevent the Wnt/-catenin signalling pathway from
being activated within the AFB.
Normal fate of Hesx1-expressing cells
The fate of Hesx1-expressing cells in our study is in agreement with
previous fate mapping studies in the mouse. Soon after the onset of
gastrulation, the anterior visceral endoderm is displaced towards the
extraembryonic region by the definitive endoderm, which is formed
at the tip of the primitive streak (Lawson and Pedersen, 1987;
Thomas and Beddington, 1996). X-Gal staining of
Hesx1Cre/+;R26Cond-lacZ/Cond-lacZ embryos detected patches of blue
cells in the visceral endoderm of the extraembryonic region from
late streak stages. It was noticeable that lacZ-expressing cells
remained clumped together and, as previously described, not much
intermingling was observed (Gardner and Cockroft, 1998). Hesx1 is
expressed in the axial levels of the anterior definitive endoderm, an
area containing the precursors of some anterior foregut derivatives
(Lawson and Pedersen, 1987; Thomas et al., 1998). In fact,
lacZ-expressing cells colonised the anterior foregut in
Hesx1Cre/+;R26Cond-lacZ/+ embryos at 8.5 dpc and were found in its
derivatives, including pharyngeal endoderm, thyroid gland, liver and
ventral pancreas.
Strong X-Gal staining was detected in the Rathke’s pouch from
9.0 dpc onwards. Interestingly, blue cells mainly colonised the
anterior and intermediate lobes, both of which are derived from the
oral ectoderm, but blue cells were rarely observed in the posterior
pituitary, which has neural origin from a recess in the floor of the
hypothalamus (see Fig. S4E in the supplementary material).
Cell fate analysis of lacZ-expressing cells within the NP showed
that the majority of the labelled cells colonised the forebrain region
anterior to the ZLI, i.e. telencephalon, eyes, hypothalamus and
ventral diencephalon. Only scattered cells ended up in the dorsal
thalamus and pretectum and, very rarely, lacZ-expressing cells
crossed the forebrain-midbrain boundary. Therefore, Hesx1 marks
only prospective forebrain, in particular the AFB.
Anterior to posterior transformation of the
forebrain in Hesx1-deficient embryos
A main finding of this study is that the absence of Hesx1 brings
about a posterior transformation of the AFB, which is evidenced by
rostral expansion of the expression domains of the NC markers
Foxd3 and Pax3, prior to an overt morphological defect of the
anterior NP. Numerous fate mapping studies have demonstrated that
premigratory NC cells are dorsal cell types that form at the border
of the NP, from mid-diencephalon to spinal cord levels, but not
rostral to the mid-diencephalon (Couly and Le Douarin, 1987;
Sechrist et al., 1995; Muhr et al., 1997). However, cells within this
NC-free region can be induced to form NC when exposed to
caudalising signals in explant experiments (Muhr et al., 1997). We
believe that the Hesx1 expression domain in the anterior NP
corresponds to this crest-free area. For instance, X-Gal staining of
Hesx1Cre/+;R26Cond-lacZ/+ embryos, which are phenotypically normal,
showed that the majority of lacZ-expressing cells colonised the AFB
and did not form NC. By contrast, lacZ-expressing cells populated
the posterior forebrain in Hesx1Cre/–;R26Cond-lacZ/+ mutants, thus
reaching the area of the NP that yields migratory NC of the first
branchial arch and the frontonasal mass (Inoue et al., 2000; Creuzet
et al., 2005).
The expression domains of Wnt3a, Wnt1, Atx and Pax6 were
expanded rostrally and lacZ-expressing cells were found throughout
the dorsoventral axis of the dorsal thalamus and pretectum. This
suggests that in the absence of Hesx1, cells initially specified to AFB
fates colonise the entire segment of the posterior forebrain, not only
NC-generating regions. However, the size of the posterior forebrain
is not affected in Hesx1-deficient embryos at 12.5-18.5 dpc, possibly
because the increased cell death in the posterior forebrain
compensates for the excess of cells populating this region.
Although required for the maintenance of AFB identity, Hesx1
cannot alter posterior fates in caudal neural tissue when
misexpressed in the mouse embryo. To do so, Hesx1 might require
specific co-factors only present in anterior and not posterior neural
tissue. (see Fig. S6 in the supplementary material) (Ermakova et al.,
1999). The partial rescue of the forebrain defects and attenuation of
the posterior transformation observed in Hesx1Cre/Cre;R26Cond-Hesx1/+
and Hesx1Cre/Cre;R26Cond-Hesx1/Cond-Hesx1 compound embryos suggest
that only the AFB is competent to respond to HESX1. Overall, these
data indicate that Hesx1 is required for AFB development but, on its
own, it is not sufficient to promote AFB fates.
The genetic rescue experiments have revealed that whereas one
copy of R26-Cond-Hesx1 in a Hesx1-null background is sufficient to
improve telencephalic development, two copies of the R26-Cond-
Hesx1 allele are required to rescue both telencephalon and eye
development. Although we cannot rule out the possibility that
telencephalic and eye precursors could express different levels of
Hesx1 from the R26 locus, we think that our experiments point to a
differential sensitivity of the eye and telencephalon to Hesx1 levels.
Fate mapping studies in the mouse embryo have shown that
telencephalic precursors reside in the rostrolateral regions of the
anterior NP and that the eye field is located caudal to this and more
medially (Inoue et al., 2000). It is worth noting that Hesx1 expression
is higher in the area of the NP that is thought to correspond to the eye
field (Thomas and Beddington, 1996). In this scenario, eye
development is expected to be more sensitive than telencephalic
development to HESX1 levels, and indeed, Hesx1-deficient embryos
show a higher penetrance of eye versus telencephalic abnormalities.
In agreement with this concept, mutant mice bearing a single amino
acid change in position 26 that yields a HESX1 protein with reduced
repressing activity (Carvalho et al., 2003), display eye abnormalities
but have normal telencephalic development (our unpublished results).
This suggests that Hesx1 might have a dual role within the anterior
NP: to promote anterior versus posterior forebrain development and
to segregate telencephalic and eye field identities (Stigloher et al.,
2006; Mathers et al., 1997).
Hesx1 antagonises caudalising signals within the
NP
Our data strongly suggest that the mechanism underlying the
posterior transformation of Hesx1–/– mutants is the ectopic activation
of Wnt/-catenin signalling within the prospective AFB at early
somite stages. Experiments in Xenopus and zebrafish have indicated
that the eye is the most sensitive region of the NP to Wnt/-catenin
activation (Fredieu et al., 1997; van de Water et al., 2001). When
zebrafish embryos were exposed for a short time to LiCl, an inhibitor
of Gsk3 that enhances Wnt/-catenin signalling, only eye
development was disrupted and the treated embryos displayed
microphthalmia or anophthalmia. However, when embryos were
treated with LiCl for longer, they developed telencephalic as well as
eye defects. An excess of Wnt/-catenin signalling might explain
the reduction in the AFB markers Six3 and Pax6 and the concomitant
rostral expansion of the NC markers Pax3 and Foxd3.
It seems likely that Hesx1 and Six3 might work in parallel in the
maintenance of AFB identity, but through distinct mechanisms.
Hesx1 can bind to Wnt1 regulatory elements in in-vitro assays, but
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it cannot repress reporter vectors containing Wnt1 regulatory
elements (see Fig. S7 in the supplementary material). Moreover,
expansion of the Sp5 expression domain occurs prior to Wnt1
rostralisation in Hesx1–/– mutants. Therefore, in contrast to the
Six3–/– mutants, ectopic Wnt1 expression within the prospective
AFB might not be the primary reason for the forebrain defects;
rather, the excess of Wnt1 might contribute to the final
morphological defects later in development.
The possibility exists that Hesx1 may antagonise Wnt/-catenin
signalling by modulating the activity of some component(s) of the
pathway causing a cell-autonomous inhibition within Hesx1-
expressing cells. Alternatively, or in addition, Hesx1 might repress
one or more Wnt/-catenin target genes directly, thus preventing the
acquisition of posterior fates. Chimeric experiments suggest that
Hesx1 is required cell-autonomously within the NP (Martinez-
Barbera et al., 2000). However, Hesx1 function can be partially
compensated for, as most Hesx1–/– mutants show some AFB
development. Moreover, in chimeric embryos, Hesx1-deficient cells,
as well as wild-type cells, can also colonise the AFB. The possibility
exists that a subset of Hesx1–/– cells might be more susceptible to
respond to Wnt/-catenin signalling and acquire a posterior fate, but
this might be difficult to observe in chimeric embryos, where the
bulk of wild-type cells can colonise the same regions of the neural
tube (Martinez-Barbera et al., 2000). Notably, the forebrain defects
were completely rescued only in embryos with a high degree of
chimerism, and the AFB was mainly populated with wild-type cells
(Martinez-Barbera et al., 2000). Future research will elucidate the
molecular function of Hesx1.
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